Way 316606 is the drug for the treatment of hair loss dwindled, perhaps due more to commercial potential and chemical stability reasons than efficacy as the later studies of Setipiprant have focused on different chemical forms of the drug and combining it with various nanoparticles to enhance delivery.
A compound originally developed to treat osteoporosis called way-316606 works by the same mechanism as CsA, specifically against SFRP1.When he treated hair follicles with way-316606, the unrelated drug was as effective as CsA in promoting hair growth.He suggests that applying way-316606 or similar compounds externally to the scalp of a bald person may promote hair growth to the same or better degree that can be achieved with CsA, without side effects.
